COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,197 Articles (22,204 medRxiv, 7,993 bioRxiv)

Most recent first Previous |  Page 331: Articles 3301-3310  | Next

Mechanism of the Covalent Inhibition of Human Transmembrane Protease Serine 2 as an Original Antiviral Strategy
Spinello, A., D'Anna, L., Bignon, E., Miclot, T., Grandemange, S., Terenzi, A., Barone, G., Barbault, F., MONARI, A.
10.1101/2023.04.23.537985 — Posted: 2023-04-24
The enigma of the SARS-CoV-2 microcirculation dysfunction: evidence for modified endothelial junctions.
Bouillet, L., Benmarce, M., Guerin, C., Bouvet, L., Garnier, O., Martin, D., Vilgrain, I.
10.1101/2023.04.24.538100 — Posted: 2023-04-24
SARS-CoV-2 Nonstructural Proteins 3 and 4 tune the Unfolded Protein Response
Davies, J. P., Sivadas, A., Keller, K. R., Wojcikiewicz, R. J., Plate, L.
10.1101/2023.04.22.537917 — Posted: 2023-04-24
Assessing Willingness to receive COVID-19 Vaccines, associated factors and reasons for hesitancy among persons aged 13-80 years in Central Uganda. A population-based surveillance Cohort.
DAAMA, A., Naziru, R., Kasango, A., Kigozi Nalwoga, G., Nalugoda, F., Bulamba, R., Kyasanku, E., Nakigozi, G., Kigozi, G., Kagaayi, J., Mugamba, S.
10.1101/2023.04.19.23288804 — Posted: 2023-04-23
COVID-19 Prevalence and Trends Among Pregnant and Postpartum Individuals in Maine by Rurality and Pregnancy Conditions
Grantham, C. O., Ackerman-Banks, C. M., Lipkind, H. S., Palmsten, K., Ahrens, K. A.
10.1101/2023.04.21.23288878 — Posted: 2023-04-23
Evaluation of coronavirus decay in French coastal water and application to SARS-CoV-2 risk evaluation using Porcine Epidemic Diarrhea Virus as surrogate.
Contrant, M., Bigault, L., Andraud, M., Desdouits, M., Rocq, S., Le Guyader, S. F., Blanchard, Y.
10.1101/2023.04.18.23288060 — Posted: 2023-04-21
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies
Atanasoff, K. E., Brambilla, L., Adelsberg, D. C., Kowdle, S. S., Stevens, C. S., Hung, C.-t., Fu, Y., Lim, R., Tran, L., Allen, R., Duty, J. A., Bajic, G., Lee, B., Tortorella, D.
10.1101/2023.04.20.537738 — Posted: 2023-04-21
Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity
Martinez-Arribas, B., Annang, F. B., Diaz-Gonzalez, R., Perez-Moreno, G., Martin, J., Mackenzie, T. A., Castillo, F., Reyes, F., Genilloud, O., Ruiz-Perez, L. M., Vicente, F., Ramos, M. C., Gonzalez-Pacanowska, D.
10.1101/2023.04.20.537680 — Posted: 2023-04-21
Outcomes of non-hospitalized isolation service during COVID-19 pandemic
Tansawet, A.
10.1101/2023.04.19.23288791 — Posted: 2023-04-20
The Effect of COVID-19 Public Health Measures On Mental Health in California
Asgari Mehrabadi, M., Nurmi, E., Borelli, J., Lambert, N., Rahmani, A. M., Downs, C. A., Pinto, M. D.
10.1101/2023.04.17.23288661 — Posted: 2023-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).